A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)
一项针对难治性或复发性实体瘤儿童的新型微管靶向化疗药物甲磺酸艾立布林 (E7389) 的 1 期研究：儿童肿瘤协作组 1 期联盟研究 (ADVL1314)
期刊:Pediatric Blood & Cancer
影响因子:2.3
doi:10.1002/pbc.27066
Schafer, Eric S; Rau, Rachel E; Berg, Stacey; Liu, Xiaowei; Minard, Charles G; D'Adamo, David; Scott, Rachael; Reyderman, Larisa; Martinez, Gresel; Devarajan, Sandhya; Reid, Joel M; Fox, Elizabeth; Weigel, Brenda J; Blaney, Susan M
